Literature DB >> 2298350

Hepatic iron overload: diagnosis and quantification by noninvasive imaging.

J L Chezmar1, R C Nelson, J A Malko, M E Bernardino.   

Abstract

The diagnostic efficacy of magnetic resonance (MR) and computed tomography (CT) for detection and quantification of hepatic iron was assessed in a series of patients under investigation for clinical or biochemical evidence of hepatic iron overload. Thirty patients underwent MR imaging (SE 30,60/1000 or SE 30,60/2000) at 0.5 Tesla with calculation of hepatic T2 and liver to paraspinous muscle signal intensity ratios. Twenty-nine patients also had measurement of hepatic attenuation on noncontrast CT images. Results of these imaging studies were correlated in all patients with quantitative iron determination from liver biopsy specimens. The best predictor of liver iron among parameters studied was the ratio of the signal intensities of liver and paraspinous muscle (L/M) on a SE 60/1000 sequence. Both MR using L/M ratios and CT were sensitive methods for detection of severe degrees of hepatic iron overload with 100% of patients with hepatic iron on biopsy greater than 600 micrograms/100 mg liver dry weight detected on the basis of L/M less than 0.6 or CT attenuation greater than 70 Hounsfield units (HU). The MR parameter, however, was more specific than CT (100 vs 50%) and showed a higher degree of correlation with quantitated hepatic iron from biopsy. T2 measurements showed poor correlation with hepatic iron, due to difficulty in obtaining precise T2 measurements in vivo when the signal intensity is low. None of the parameters utilized was sensitive for detecting mild or moderate degrees of hepatic iron overload. We conclude that MR and CT are sensitive techniques for noninvasive detection of severe hepatic iron overload, with MR providing greater specificity than CT.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298350     DOI: 10.1007/BF01888728

Source DB:  PubMed          Journal:  Gastrointest Radiol        ISSN: 0364-2356


  12 in total

1.  MR evaluation of liver iron overload.

Authors:  R J Hernandez; S A Sarnaik; I Lande; A M Aisen; G M Glazer; T Chenevert; W Martel
Journal:  J Comput Assist Tomogr       Date:  1988 Jan-Feb       Impact factor: 1.826

Review 2.  Iron storage disorders of the liver.

Authors:  N D Grace; L W Powell
Journal:  Gastroenterology       Date:  1974-12       Impact factor: 22.682

3.  Determination of chelated iron in the urine.

Authors:  M Barry
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

4.  Nuclear magnetic resonance imaging of experimentally induced liver disease.

Authors:  D D Stark; N M Bass; A A Moss; B R Bacon; J H McKerrow; C E Cann; A Brito; H I Goldberg
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

5.  Measurement of signal intensities in the presence of noise in MR images.

Authors:  R M Henkelman
Journal:  Med Phys       Date:  1985 Mar-Apr       Impact factor: 4.071

6.  Diagnostic efficacy of hepatic computed tomography in the detection of body iron overload.

Authors:  J M Howard; C N Ghent; L S Carey; P R Flanagan; L S Valberg
Journal:  Gastroenterology       Date:  1983-02       Impact factor: 22.682

7.  Computed tomography for determining liver iron content in primary haemochromatosis.

Authors:  R W Chapman; G Williams; G Bydder; R Dick; S Sherlock; L Kreel
Journal:  Br Med J       Date:  1980-02-16

8.  Magnetic resonance imaging of transfusional hemosiderosis complicating thalassemia major.

Authors:  R C Brasch; G E Wesbey; C A Gooding; M A Koerper
Journal:  Radiology       Date:  1984-03       Impact factor: 11.105

9.  Nuclear magnetic resonance of iron and copper disease states.

Authors:  V M Runge; J A Clanton; F W Smith; J Hutchison; J Mallard; C L Partain; A E James
Journal:  AJR Am J Roentgenol       Date:  1983-11       Impact factor: 3.959

10.  Noninvasive quantitation of liver iron in dogs with hemochromatosis using dual-energy CT scanning.

Authors:  H I Goldberg; C E Cann; A A Moss; M Ohto; A Brito; M Federle
Journal:  Invest Radiol       Date:  1982 Jul-Aug       Impact factor: 6.016

View more
  8 in total

1.  Prenatal diagnosis of idiopathic neonatal hemochromatosis with MRI.

Authors:  L Martí-Bonmatí; A Baamonde; C R Poyatos; E Monteagudo
Journal:  Abdom Imaging       Date:  1994 Jan-Feb

2.  Hepatic iron overload in thalassemic patients: proposal and validation of an MRI method of assessment.

Authors:  M G Bonetti; A Castriota-Scanderbeg; G M Criconia; P Mazza; M Sacco; B Amurri; C Masi
Journal:  Pediatr Radiol       Date:  1996-09

Review 3.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

4.  Magnetic resonance imaging of the heart in a case of hepatocellular carcinoma extending into the right atrium.

Authors:  P Dendale; B op de Beeck; F de Ridder; F Claessens; M Osteaux; P Block
Journal:  Int J Card Imaging       Date:  1994-09

5.  Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results.

Authors:  Jens-Peter Kühn; Diego Hernando; Alejandro Muñoz del Rio; Matthias Evert; Stephan Kannengiesser; Henry Völzke; Birger Mensel; Ralf Puls; Norbert Hosten; Scott B Reeder
Journal:  Radiology       Date:  2012-08-24       Impact factor: 11.105

6.  MRI of hepatic iron deposition in patients with renal transplant.

Authors:  F H Miller; M R Fisher; W Soper; R M Gore
Journal:  Gastrointest Radiol       Date:  1991

Review 7.  MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.

Authors:  Maria I Argyropoulou; Loukas Astrakas
Journal:  Pediatr Radiol       Date:  2007-08-21

8.  Value of liver iron concentration in healthy volunteers assessed by MRI.

Authors:  Marzanna Obrzut; Vitaliy Atamaniuk; Kevin J Glaser; Jun Chen; Richard L Ehman; Bogdan Obrzut; Marian Cholewa; Krzysztof Gutkowski
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.